A Neoantigen-Based Peptide Vaccine for Patients With Advanced Pancreatic Cancer Refractory to Standard Treatment

BACKGROUND: Neoantigens are critical targets to elicit robust antitumor T-cell responses. Personalized cancer vaccines developed based on neoantigens have shown promising results by prolonging cancer patients’ overall survival (OS) for several cancer types. However, the safety and efficacy of these...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zheling, Zhang, Shanshan, Han, Ning, Jiang, Jiahong, Xu, Yunyun, Ma, Dongying, Lu, Lantian, Guo, Xiaojie, Qiu, Min, Huang, Qinxue, Wang, Huimin, Mo, Fan, Chen, Shuqing, Yang, Liu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414362/
https://www.ncbi.nlm.nih.gov/pubmed/34484187
http://dx.doi.org/10.3389/fimmu.2021.691605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414362/
https://www.ncbi.nlm.nih.gov/pubmed/34484187
http://dx.doi.org/10.3389/fimmu.2021.691605

Ejemplares similares